November 26, 2012

Topics covered: Biotechnology and Pharmaceutical Investing

Companies covered: WellPoint Inc., WellCare Health Plans, Inc. (NYSE:WCG), UnitedHealth Group Incorporated (NYSE:UNH), Molina Healthcare Inc (NYSE:MOH), Healthways, Inc. (NASDAQ:HWAY), Humana Inc. (NYSE:HUM), Coventry Health Care Inc., Centene Corporation (NYSE:CNC), Cigna Corporation (NYSE:CI), AMERIGROUP Corp., Aetna Inc. (NYSE:AET), Trinity Biotech plc (NASDAQ:TRIB), Enzo Biochem, Inc. (NYSE:ENZ), Community Health Systems, Inc. (NYSE:CYH), Celgene Corporation (NASDAQ:CELG), Biogen Idec Inc. (NASDAQ:BIIB), Amgen Inc. (NASDAQ:AMGN), Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN), Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), Seattle Genetics, Inc. (NASDAQ:SGEN), Pfizer, Inc. (NYSE:PFE), Pharmacyclics, Inc. (NASDAQ:PCYC), Merck & Company, Inc. (NYSE:MRK), Incyte Corporation (NASDAQ:INCY), Idenix Pharmaceuticals Inc., Gilead Sciences, Inc. (NASDAQ:GILD), Bristol-Myers Squibb Company (NYSE:BMY), Celldex Therapeutics, Inc. (NASDAQ:CLDX), Pluristem Therapeutics, Inc. (NASDAQ:PSTI), ImmunoGen, Inc. (NASDAQ:IMGN), Curis, Inc. (NASDAQ:CRIS), ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA), United Therapeutics Corporation (NASDAQ:UTHR), Synta Pharmaceuticals Corp. (NASDAQ:SNTA), Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL), Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN), Onyx Pharmaceuticals Inc., Isis Pharmaceuticals, Inc. (NASDAQ:ISIS), Thermo Fisher Scientific Inc (NYSE:TMO), Medtronic, Inc. (NYSE:MDT), Life Technologies Corporation, Illumina, Inc. (NASDAQ:ILMN), Hologic, Inc. (NASDAQ:HOLX), Edwards Lifesciences Corporation (NYSE:EW), Agilent Technologies, Inc. (NYSE:A), Siemens AG, Koninklijke Philips N.V. (NYSE:PHG), Mindray Medical International Limited (NYSE:MR), Johnson & Johnson (NYSE:JNJ), General Electric Company (NYSE:GE), FedEx Corporation (NYSE:FDX), Universal Health Services, Inc. (NYSE:UHS), HealthSouth Corporation (NYSE:HLS), Amsurg Corp. (NASDAQ:AMSG), NxStage Medical, Inc. (NASDAQ:NXTM), MWI Veterinary Supply, Inc. (NASDAQ:MWIV), Mednax, Inc (NYSE:MD), Laboratory Corporation of America Holdings (NYSE:LH), DaVita healthCare Partners Inc. (NYSE:DVA), Quest Diagnostics Incorporated (NYSE:DGX)

Buy ($175)

Pin It on Pinterest

Share This